Diabetes Pill FDA

FILE - In this June 30, 2010 file photo, a pharmacist holds a bottle of Avandia pills at Maximart Pharmacy in Palo Alto, Calif. Federal health advisers discuss whether GlaxoSmithKline's diabetes pill Avandia should be pulled from the market. The one-time-blockbuster drug's sales have shrunk markedly since studies suggested potential ties to heart attacks. (AP Photo/Paul Sakuma, file)